脆弱拟杆菌群各菌种对10种抗菌剂的敏感性。
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.
作者信息
Betriu C, Campos E, Cabronero C, Rodriguez-Avial C, Picazo J J
机构信息
Servicio de Microbiología Clínica, Hospital Universitario San Carlos, Madrid, Spain.
出版信息
Antimicrob Agents Chemother. 1990 Apr;34(4):671-3. doi: 10.1128/AAC.34.4.671.
Abstract
A total of 94 clinical isolates of the Bacteroides fragilis group was tested for susceptibility to metronidazole, chloramphenicol, clindamycin, cefoxitin, cefotetan, cefmetazole, moxalactam, mezlocillin, amoxicillin-clavulanic acid, and imipenem. All the strains tested were susceptible to imipenem, metronidazole, amoxicillin-clavulanic acid, and chloramphenicol. The rate of resistance to clindamycin was 21%. The results of this study demonstrate a difference in resistance rates from one species of the B. fragilis group to another.
摘要
共对94株脆弱拟杆菌属的临床分离株进行了甲硝唑、氯霉素、克林霉素、头孢西丁、头孢替坦、头孢美唑、拉氧头孢、美洛西林、阿莫西林-克拉维酸和亚胺培南的药敏试验。所有受试菌株对亚胺培南、甲硝唑、阿莫西林-克拉维酸和氯霉素敏感。对克林霉素的耐药率为21%。本研究结果表明，脆弱拟杆菌属的不同菌种之间耐药率存在差异。
相似文献
1
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.脆弱拟杆菌群各菌种对10种抗菌剂的敏感性。
Antimicrob Agents Chemother. 1990 Apr;34(4):671-3. doi: 10.1128/AAC.34.4.671.
2
Evolution of antimicrobial susceptibility in isolates of the Bacteroides fragilis group in Spain.西班牙脆弱拟杆菌群菌株的抗菌药物敏感性演变
Rev Infect Dis. 1990 Jan-Feb;12 Suppl 2:S142-51. doi: 10.1093/clinids/12.supplement_2.s142.
3
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.脆弱拟杆菌群近期社区获得性分离株的年发病率、流行病学以及对头孢西丁、头孢替坦、头孢美唑和头孢唑肟的体外敏感性比较
J Clin Microbiol. 1988 Nov;26(11):2361-6. doi: 10.1128/jcm.26.11.2361-2366.1988.
4
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.脆弱拟杆菌群各菌种对新型β-内酰胺类药物的体外敏感性
J Antimicrob Chemother. 1999 Jan;43(1):133-6. doi: 10.1093/jac/43.1.133.
5
In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.阿莫西林和替卡西林与克拉维酸联合使用的体外活性与新型β-内酰胺类药物针对脆弱拟杆菌群各菌种的活性比较。
J Antimicrob Chemother. 1986 May;17(5):593-603. doi: 10.1093/jac/17.5.593.
6
Survey of Bacteroides fragilis group susceptibility patterns in Canada.加拿大脆弱拟杆菌群药敏模式调查。
Antimicrob Agents Chemother. 1992 Feb;36(2):343-7. doi: 10.1128/AAC.36.2.343.
7
Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.欧洲脆弱拟杆菌群的抗生素敏感性。欧洲研究小组。
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):292-304. doi: 10.1007/BF01962068.
8
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.美国1292株脆弱拟杆菌属细菌的药敏情况：1981年与1982年的比较
Antimicrob Agents Chemother. 1984 Aug;26(2):145-8. doi: 10.1128/AAC.26.2.145.
9
Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.在三个医学中心对脆弱拟杆菌群的物种对五种抗菌药物的敏感性进行的纵向研究。
Antimicrob Agents Chemother. 1994 Oct;38(10):2276-9. doi: 10.1128/AAC.38.10.2276.
10
Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.1989年美国脆弱拟杆菌群的抗菌药敏模式
Clin Ther. 1992 Jan-Feb;14(1):122-36.
引用本文的文献
1
In vitro susceptibility to selected antibiotics in bacteria of the Bacteroides fragilis group.脆弱拟杆菌群细菌对所选抗生素的体外敏感性
Folia Microbiol (Praha). 2009;54(4):353-8. doi: 10.1007/s12223-009-0050-5. Epub 2009 Oct 14.
2
Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.脆弱拟杆菌临床分离株中β-内酰胺酶的药敏模式及特性
Eur J Clin Microbiol Infect Dis. 1994 Jun;13(6):475-80. doi: 10.1007/BF01974637.
3
In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp.甲硝唑及其羟基代谢物对拟杆菌属的体外活性
Antimicrob Agents Chemother. 1994 Sep;38(9):2106-10. doi: 10.1128/AAC.38.9.2106.
4
Susceptibility testing of anaerobic bacteria: myth, magic, or method?厌氧菌的药敏试验：神话、魔法还是方法？
Clin Microbiol Rev. 1991 Oct;4(4):470-84. doi: 10.1128/CMR.4.4.470.
5
In vitro susceptibilities of the Bacteroides fragilis group to 14 antimicrobial agents in Korea.韩国脆弱拟杆菌群对14种抗菌药物的体外敏感性
Antimicrob Agents Chemother. 1992 Jan;36(1):195-7. doi: 10.1128/AAC.36.1.195.
6
Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents.脆弱拟杆菌群成员对11种抗菌药物的敏感性
Antimicrob Agents Chemother. 1992 Sep;36(9):2051-3. doi: 10.1128/AAC.36.9.2051.
7
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.1979 - 1989年间脆弱拟杆菌属菌群对各种抗菌药物敏感性的变化
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):352-6. doi: 10.1007/BF01962077.
8
Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.欧洲脆弱拟杆菌群的抗生素敏感性。欧洲研究小组。
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):292-304. doi: 10.1007/BF01962068.
9
Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.1977年至1992年法国脆弱拟杆菌群菌株药敏模式调查。
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1094-9. doi: 10.1007/BF01967804.
10
German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study Group.德国关于拟杆菌属体外药敏性的多中心研究。德国拟杆菌研究小组。
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1074-80. doi: 10.1007/BF01967802.
本文引用的文献
1
Bacteroides fragilis resistance to clindamycin in vitro.脆弱拟杆菌对克林霉素的体外耐药性。
Antimicrob Agents Chemother. 1982 Nov;22(5):771-4. doi: 10.1128/AAC.22.5.771.
2
Differences in susceptibilities of species of the Bacteroides fragilis group to several beta-lactam antibiotics: indole production as an indicator of resistance.脆弱拟杆菌群不同菌种对几种β-内酰胺类抗生素敏感性的差异：吲哚产生作为耐药性的指标
Antimicrob Agents Chemother. 1982 Oct;22(4):628-34. doi: 10.1128/AAC.22.4.628.
3
Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.来自法国几家医院的厌氧菌对三种主要抗生素的敏感性
Antimicrob Agents Chemother. 1984 Jun;25(6):764-6. doi: 10.1128/AAC.25.6.764.
4
Increasing incidence of clinical isolates of Bacteroides fragilis resistant to clindamycin.脆弱拟杆菌临床分离株对克林霉素耐药的发生率不断上升。
J Antimicrob Chemother. 1984 Apr;13(4):395. doi: 10.1093/jac/13.4.395.
5
Inhibitory activity of cefotetan and other beta-lactams against anaerobes.
J Antimicrob Chemother. 1983 Jan;11 Suppl:107-15. doi: 10.1093/jac/11.suppl_a.107.
6
Epidemiology of clindamycin resistance in the Bacteroides fragilis group.脆弱拟杆菌群中克林霉素耐药性的流行病学
J Antimicrob Chemother. 1984 Dec;14(6):595-603. doi: 10.1093/jac/14.6.595.
7
The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid.脆弱拟杆菌群对阿莫西林-克拉维酸的体外敏感性
J Antimicrob Chemother. 1984 Oct;14(4):367-72. doi: 10.1093/jac/14.4.367.
8
Antimicrobial susceptibilities of 1,292 isolates of the Bacteroides fragilis group in the United States: comparison of 1981 with 1982.美国1292株脆弱拟杆菌属细菌的药敏情况：1981年与1982年的比较
Antimicrob Agents Chemother. 1984 Aug;26(2):145-8. doi: 10.1128/AAC.26.2.145.
9
Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.美国全国范围内脆弱拟杆菌群药敏性研究。
Antimicrob Agents Chemother. 1985 Nov;28(5):675-7. doi: 10.1128/AAC.28.5.675.
10
In vitro activity of cefbuperazone against Bacteroides spp.头孢哌酮舒巴坦对拟杆菌属的体外活性
Antimicrob Agents Chemother. 1985 Jun;27(6):968-70. doi: 10.1128/AAC.27.6.968.
Zotero 插件